Equity Overview
Price & Market Data
Price: $2.63
Daily Change: -$0.0554 / 2.10%
Range: $2.58 - $2.72
Market Cap: $22,652,818
Volume: 12,521
Performance Metrics
1 Week: -3.85%
1 Month: 10.94%
3 Months: 13.07%
6 Months: -3.81%
1 Year: -15.69%
YTD: -11.59%
Company Details
Employees: 26
Sector: Health technology
Industry: Pharmaceuticals: major
Country: United States
Details
Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company, engages in the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product is certepetide, which is in Phase 2 clinical studies for the treatment of solid tumors, such as metastatic pancreatic ductal adenocarcinoma, cholangiocarcinoma, appendiceal cancer, and colon cancer and glioblastoma multiforme in combination with a range of anti-cancer regimens. The company was incorporated in 1980 and is headquartered in Basking Ridge, New Jersey.